FDA — authorised 19 September 2008
- Marketing authorisation holder: GE HEALTHCARE
- Status: approved
FDA authorised Adreview on 19 September 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 19 September 2008.
GE HEALTHCARE holds the US marketing authorisation.